Osteosclerotic plasma cell myeloma

Cancer of plasma cells characterized by osteosclerosis

Not to be confused with Multiple myeloma.

Osteosclerotic plasma cell myeloma
Plasmacytoma_ultramini1.jpg
Micrograph of a plasmacytoma with osteosclerotic changes, H&E stain
Specialty	Hematology and oncology
Symptoms	Bone pain, fatigue, fractures
Complications	Amyloidosis, kidney disease, pathologic fractures, anemia, infections, nerve damage
Usual onset	Gradual
Duration	Long term
Causes	Unknown
Risk factors	Obesity, genetic predisposition
Diagnosis	Blood test, urine test, bone marrow biopsy, medical imaging
Treatment	Steroids, chemotherapy, stem cell transplantation, bisphosphonates, radiation therapy
Prognosis	Variable based on stage and treatment
Frequency	Rare

Osteosclerotic plasma cell myeloma is a rare subtype of plasma cell neoplasm characterized by osteosclerosis, a condition in which abnormal hardening occurs in the bones. This variant is distinct from other forms of multiple myeloma due to its association with bone formation abnormalities and fibrotic changes in the bone trabeculae.

Pathophysiology

Osteosclerotic plasma cell myeloma involves the proliferation of abnormal plasma cells within the bone marrow, which leads to the replacement of normal bone marrow elements. Unlike traditional osteolytic lesions seen in classic multiple myeloma, this subtype is marked by osteosclerosis, resulting in increased bone density. These changes are due to the interaction between cancerous plasma cells and osteoblasts, the cells responsible for bone formation.

The disease is also linked to excessive production of monoclonal antibodies by plasma cells, which can cause hyperviscosity syndrome, kidney damage, and immune suppression.

Clinical Features

Common symptoms include:

• Persistent bone pain, often in the spine, ribs, and pelvis
• Fatigue caused by anemia
• Pathologic fractures due to weakened bone structures
• Increased susceptibility to infections due to impaired immune function

Patients may also present with systemic complications such as hypercalcemia and kidney dysfunction.

Diagnosis

Diagnosis is typically made through a combination of:

• Blood tests to detect abnormal proteins (e.g., M protein) and assess kidney function
• Urine tests to identify Bence Jones proteins
• Bone marrow biopsy to evaluate plasma cell infiltration
• Medical imaging techniques like X-rays, CT scans, and MRI to identify osteosclerotic changes

In some cases, PET scans are used to assess the extent of disease spread.

Associated Conditions

1. 1. 1. Lymph Node Changes

In osteosclerotic plasma cell myeloma, lymph nodes may exhibit changes resembling those seen in Castleman disease, a rare condition characterized by abnormal growth of lymphoid tissue.

1. 1. 1. POEMS Syndrome

This subtype is frequently associated with POEMS syndrome, which stands for:

• **P**olyneuropathy (nerve damage causing weakness or numbness)
• **O**rganomegaly (enlargement of organs such as the liver or spleen)
• **E**ndocrinopathy (hormonal imbalances, such as diabetes or hypothyroidism)
• **M**onoclonal gammopathy (presence of abnormal monoclonal proteins)
• **S**kin changes (including thickening, hyperpigmentation, or increased hair growth)

Treatment

Treatment options for osteosclerotic plasma cell myeloma include:

• **Chemotherapy**: Standard regimens to reduce plasma cell proliferation
• **Steroids**: To manage inflammation and enhance the effects of chemotherapy
• **Stem cell transplantation**: For eligible patients, this offers the potential for long-term remission
• **Bisphosphonates**: To strengthen bones and reduce the risk of fractures
• **Radiation therapy**: Targeted treatment for localized bone pain or lesions

Prognosis

The prognosis for osteosclerotic plasma cell myeloma varies depending on the stage of the disease and response to treatment. While some patients achieve remission, others may experience disease progression. Early diagnosis and comprehensive management improve outcomes.

Epidemiology

Osteosclerotic plasma cell myeloma is a rare condition, representing a small fraction of multiple myeloma cases. It is more commonly diagnosed in older adults and shows a slight male predominance.

See Also

• Multiple myeloma
• POEMS syndrome
• Castleman disease
• Monoclonal gammopathy of undetermined significance (MGUS)